CASP8 and cervical carcinoma: Notably, our research underscored that combining a small-molecule CDK9 inhibitor with Cisplatin elicited a synergistic inhibition of the cervical cancer cell growth under both 2D and 3D culture conditions, particularly in cases lacking Caspase-8 expression [16,17].